Reese, Melinda J <br/><br/>
Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam.  [electronic resource] 

 -  Xenobiotica; the fate of foreign compounds in biological systems  2016 
 - 445-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1366-5928 
<br/><br/><label>Standard No.: </label>10.3109/00498254.2015.1081993  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP-Binding Cassette Transporters--metabolism<br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Anti-HIV Agents--administration & dosage<br/>Area Under Curve<br/>Cytochrome P-450 CYP3A--chemistry<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--chemistry<br/>Hepatocytes--drug effects<br/>Humans<br/>Inhibitory Concentration 50<br/>Madin Darby Canine Kidney Cells<br/>Male<br/>Midazolam--administration & dosage<br/>Middle Aged<br/>Organic Anion Transport Protein 1--antagonists & inhibitors<br/>Organic Anion Transporters--metabolism<br/>Organic Anion Transporters, Sodium-Independent--antagonists & inhibitors<br/>Pyridones--administration & dosage<br/>Young Adult